Tubulin is a significant target in toxicology due to its critical role in cell division and function. Many anticancer drugs and other therapeutic agents interact with tubulin to disrupt microtubule dynamics, thereby inhibiting cell proliferation. This mechanism is particularly valuable in targeting rapidly dividing cancer cells. However, the disruption of tubulin can also lead to adverse effects in normal cells, contributing to the toxicity profiles of these drugs.
